Infection in systemic lupus erythematosus

Rheum Dis Clin North Am. 1998 May;24(2):423-56. doi: 10.1016/s0889-857x(05)70016-8.


The improved survival of SLE patients since the 1950s is the result of not only better treatment, but also supportive treatment of renal failure and the wealth of antibiotics now available. Ironically, the wider use of immunosuppressives, especially the alkylating drugs, and the longer survival of patients with renal insufficiency and renal failure have made the identification and appropriate treatment of infection in SLE an ongoing challenge.

Publication types

  • Review

MeSH terms

  • Bacterial Infections / complications*
  • Bacterial Infections / immunology
  • Bacterial Infections / mortality
  • Humans
  • Lupus Erythematosus, Systemic / microbiology*
  • Lupus Erythematosus, Systemic / mortality
  • Lupus Erythematosus, Systemic / virology*
  • Mycoses / complications*
  • Mycoses / immunology
  • Mycoses / mortality
  • Virus Diseases / complications*
  • Virus Diseases / immunology
  • Virus Diseases / mortality